Jingjing Pharmaceutical, as a company with over 20 years of experience in the pharmaceutical and healthcare sectors, boasts a comprehensive set of advantages that include fully equipped refining production lines, ample production capacity, a wide range of products, a professional team, advanced technology, efficient incubation capabilities, and flexible customization services. From technology research and development to the implementation of results, from raw material refinement to custom-made products, Jingjing Pharmaceutical uses its expertise to break down barriers to collaboration and offers customers a variety of customized solutions. With its multi-platform production lines that combine scale and flexibility, the company possesses a biomanufacturing technology innovation platform, a pilot-scale amplification platform, and a product incubation platform, establishing a system of seven large-scale, diversified production lines capable of independent production. These lines can quickly meet a range of demands, from small-scale samples to mass production in the thousands of tons per month. Combined with flexible customization services across the entire chain, Jingjing Pharmaceutical provides integrated solutions from raw materials to finished products, providing a solid foundation for the launch of various products. The company’s industry-academia-research collaboration and multiple technical approaches empower project incubation. Relying on years of accumulated research and development platforms, production experience, and technical reserves, Jingjing Pharmaceutical’s team is skilled in developing processes using fermentation, enzymatic catalysis, synthesis, crystallization, liposome technology, and other methods. They can provide targeted incubation for semi-mature or uncommercialized projects with technical challenges, offering full support from technical feasibility analysis to process optimization, overcoming technical difficulties and resolving industrialization bottlenecks. With its strong capabilities across the entire chain, Jingjing Pharmaceutical builds a core barrier in customization services. Adhering to the service philosophy of “meeting expectations and exceeding them,” the company has collaborated with more than 10 CRO companies on product research, development, and production. This not only helps customers avoid the high costs associated with building their own production lines but also significantly reduces the time required for product development and market launch through efficient technology transfer and large-scale production capabilities, enhancing the competitiveness and market share of the products. In the future, with the deeper application of synthetic biology technology and the continued expansion of its liposome platform, Jingjing Pharmaceutical will offer even more competitive customization solutions to customers worldwide, working with industry partners to create a new ecosystem of mutual benefit.